Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice

American Journal of Nephrology

Volumn 28, Issue 4, 2008, Pages 661-668

  Fukuoka, Naomi ^a   Sugiyama, Hitoshi ^a   Inoue, Tatsuyuki ^a   Kikumoto, Yoko ^a   Takiue, Kei Ichi ^a   Morinaga, Hiroshi ^a   Nakao, Kazushi ^a   Maeshima, Yohei ^a   Asanuma, Masato ^a   Wang, Da Hong ^a   Ogino, Keiki ^a   Masuoka, Noriyoshi ^b   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Acatalasemia, mouse study; Catalase; Lipid peroxidation products; Oxidative stress; Peritoneal dialysis, catalase depletion; Reactive oxygen species

Indexed keywords

4 HYDROXY 2 HEXENAL; 4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; CHLORHEXIDINE GLUCONATE; COLLAGEN TYPE 1; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALASE DEFICIENCY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; HOMOZYGOSITY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL FIBROSIS; PERITONEUM; PRIORITY JOURNAL; TISSUE INJURY; UPREGULATION; WILD TYPE;

ACATALASIA; ANIMALS; ASCITIC FLUID; CATALASE; CHLORHEXIDINE; DEOXYGUANOSINE; FIBROSIS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MICE; MICE, MUTANT STRAINS; OXIDANTS; PERITONEAL DIALYSIS; PERITONEUM;

EID: 45149114238     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121357     Document Type: Article

References (27)

1. Kawaguchi Y: Status of peritoneal dialysis in Japan. Perit Dial Int 2006;26:133-135.
2. Chance B, Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
3. Takahara S: Acatalasemia. Lancet 1952;2:1101-1106.
4. Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, Harada T, Ozono Y, Koji T, Kohno S: TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int 2004;66:1677-1685.
5. Tanabe K, Maeshima Y, Ichinose K, Kitayama H, Takazawa Y, Hirokoshi K, Kinomura M, Sugiyama H, Makino H: Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int 2007;71:227-238.
6. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, Makino H: Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005;68:1018-1031.
7. Masuoka N, Sugiyama H, Ishibashi N, Wang DH, Masuoka T, Kodama H, Nakano T: Characterization of acatalasemic erythrocytes treated with low and high dose hydrogen peroxide. Hemolysis and aggregation. J Biol Chem 2006;281:21728-21734.
8. Wakimoto M, Masuoka N, Nakano T, Ubuka T: Determination of glutathione peroxidase activity and its contribution to hydrogen peroxide removal in erythrocytes. Acta Med Okayama 1998;52:233-237.
9. Maruyama M, Sugiyama H, Sada K, Kobayashi M, Maeshima Y, Yamasaki Y, Makino H: Desmin as a marker of proteinuria in early stages of membranous nephropathy in elderly patients. Clin Nephrol 2007;68:73-80.
10. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y: Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int 2004;65:1927-1936.
11. Ogata M: Acatalasemia. Hum Genet 1991;86:331-340.
12. Sunami R, Sugiyama H, Wang DH, Kobayashi M, Maeshima Y, Yamasaki Y, Masuoka N, Ogawa N, Kira S, Makino H: Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol 2004;286:F1030-F1038.
13. Shostak A, Pivnik E, Gotloib L: Cultured rat mesothelial cells generate hydrogen peroxide: a new player in peritoneal defense? J Am Soc Nephrol 1996;7:2371-2378.
14. Elgawish A, Glomb M, Friedlander M, Monnier VM: Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 1996;271:12964-12971.
15. Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, Jeon JS, Ha H, Lee HB: Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int 2006;69:2022-2028.
16. Aroeira LS, Aguilera A, Sánchez-Tomero JA, Bajo MA, del Peso G, Jiménez-Heffernan JA, Selgas R, López-Cabrera M: Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007;18:2004-2013.
17. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele de Strihou C, Kurokawa K: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999;463:260-264.
18. Tan AL, Forbes JM, Cooper ME: AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol 2007;27:130-143.
19. Lee HB, Yu MR, Song JS, Ha H: Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004;65:1170-1179.
20. Sawada T, Ishii Y, Tojimbara T, Nakajima I, Fuchinoue S, Teraoka S: The ACE inhibitor, quinapril, ameliorates peritoneal fibrosis in an encapsulating peritoneal sclerosis model in mice. Pharmacol Res 2002;46:505-510.
21. Griendling KK, Ushio-Fukai M: Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000;91:21-27.
22. Feinstein RN, Suter H, Jaroslow BN: Blood catalase polymorphism: some immunological aspects. Science 1968;159:638-640.
23. Shaffer JB, Preston KE: Molecular analysis of an acatalasemic mouse mutant. Biochem Biophys Res Commun 1990;173:1043-1050.
24. Wang DH, Tsutsui K, Sano K, Masuoka N, Kira S: cDNA cloning and expression of mutant catalase from the hypocatalasemic mouse: comparison with the acatalasemic mutant. Biochim Biophys Acta 2001;1522:217-220.
25. Wang DH, Funamori Y, Ikeda S, Sato M, Kira S, Taketa K: Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine. Hepatol Res 1998;12:217-224.
26. Ho YS, Xiong Y, Ma W, Spector A, Ho DS: Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 2004;279:32804-32812.
27. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, Zhang SL, Guo DF, Filep JG, Ingelfinger JR, Chan JS: Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 2007;71:912-923.